Rosenfeld J V, Harvey A S, Wrennall J, Zacharin M, Berkovic S F
Department of Neurosurgery, Royal Children's Hospital, Melbourne, Victoria, Australia.
Neurosurgery. 2001 Jan;48(1):108-18. doi: 10.1097/00006123-200101000-00019.
Hypothalamic hamartomas (HHs) are associated with precocious puberty and gelastic epilepsy; the seizures are often refractory to antiepileptic medications and associated with delayed development and disturbed behavior. The current opinion is that surgery to treat intrahypothalamic lesions is formidable and that complete excision is not technically achievable. We report our experience with a transcallosal approach to the resection of HHs.
Five children (age, 4-13 yr) with intractable epilepsy and HHs underwent preoperative clinical, electroencephalographic, and imaging evaluations. Two patients experienced only gelastic seizures, and three patients experienced mixed seizure disorders with drop attacks; all experienced multiple daily seizures. Patients were evaluated with respect to seizures, cognition, behavior, and endocrine status 9 to 37 months (mean, 24 mo) after surgery. The HHs were approached via a transcallosal-interforniceal route to the third ventricle and were resected using a microsurgical technique and frameless stereotaxy.
Complete or nearly complete (>95%) excision of the HHs was achieved for all patients, with no adverse neurological, psychological, or visual sequelae. Two patients experienced mild transient diabetes insipidus after surgery. Two patients developed appetite stimulation, but no other significant endocrinological sequelae were observed. Three patients are seizure-free and two patients have experienced only occasional, brief, mild gelastic seizures after surgery, all with reduced antiepileptic medications. On the basis of parental reports and our own subjective observations, the children also exhibited marked improvements in behavior, school performance, and quality of life.
Complete or nearly complete resection of HHs can be safely achieved via a transcallosal approach, with the possibility of seizure freedom and neurobehavioral improvements.
下丘脑错构瘤(HHs)与性早熟和痴笑性癫痫相关;这些癫痫发作通常对抗癫痫药物难治,并与发育延迟和行为障碍有关。目前的观点认为,治疗下丘脑内病变的手术难度极大,技术上无法实现完全切除。我们报告采用经胼胝体入路切除HHs的经验。
5例患有顽固性癫痫和HHs的儿童(年龄4 - 13岁)接受了术前临床、脑电图和影像学评估。2例患者仅经历痴笑性发作,3例患者经历伴有跌倒发作的混合性癫痫发作;所有患者每天均发作多次。术后9至37个月(平均24个月)对患者的癫痫发作、认知、行为和内分泌状况进行评估。通过经胼胝体 - 穹窿间入路进入第三脑室处理HHs,并采用显微外科技术和无框架立体定向技术进行切除。
所有患者均实现了HHs的完全或近乎完全(>95%)切除,无不良神经、心理或视觉后遗症。2例患者术后出现轻度短暂性尿崩症。2例患者出现食欲亢进,但未观察到其他明显的内分泌后遗症。3例患者术后无癫痫发作,2例患者术后仅偶尔出现短暂、轻度的痴笑性发作,且均减少了抗癫痫药物的使用。根据家长报告和我们自己的主观观察,这些儿童在行为、学业表现和生活质量方面也有显著改善。
通过经胼胝体入路可以安全地实现HHs的完全或近乎完全切除,有可能实现无癫痫发作和神经行为改善。